Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical […]
Breakthrough PTSD treatment achieves 68% remission rate in clinical trial Read Post »


